Roberto Alvarez-Lafuente

14PUBLICATIONS
64CO-AUTHORS
Metabolic medicineNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Medical biochemistry - proteins and peptides (incl. medical proteomics)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 28, 2026
Bacterial Metabolites in the Plasma of Type 1 Diabetes Patients: Acetate Levels Are Elevated and Correlate with Glycated Haemoglobin and Para-Cresol Is Associated with Liver Disturbances and Hypertension.

Jiménez-Varas Inés, Cuesta-Hernández Martín, Domínguez-Mozo María Inmaculada

|Jun 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.

Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning

|Mar 04, 2025
Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile.

Maria Inmaculada Dominguez-Mozo, Daniel López-Mecández, Luisa María Villar

|Sep 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis.

María Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal

|Aug 05, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.

Enric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente

|Nov 08, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.

Nicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga

Pageof 3